Corcept Therapeutics
CORT
$25.06
Share price
4.94%
Change (1 day)
11.92%
Change (1 year)
Categories
Corcept Therapeutics (CORT) - P/B ratio
P/B ratio as of May 2024 : 5.14
According to Corcept Therapeutics
's latest financial reports the company has a price-to-book ratio of 5.14.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Corcept Therapeutics - P/B ratio (from 2004 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 6.61 | 51.66% |
| 2022-12-31 | 4.36 | -28.38% |
| 2021-12-31 | 6.08 | 4.75% |
| 2020-12-31 | 5.81 | 55.51% |
| 2019-12-31 | 3.73 | -32.97% |
| 2018-12-31 | 5.57 | -48.39% |
| 2017-12-31 | 10.8 | -44.6% |
| 2016-12-31 | 19.5 | -34% |
| 2015-12-31 | 29.5 | -132.88% |
| 2014-12-31 | -89.8 | -688.73% |
| 2013-12-31 | 15.3 | 560.05% |
| 2012-12-31 | 2.31 | -72.08% |
| 2011-12-31 | 8.28 | -37.09% |
| 2010-12-31 | 13.2 | 67.34% |
| 2009-12-31 | 7.86 | 161.86% |
| 2008-12-31 | 3.00 | -63.8% |
| 2007-12-31 | 8.29 | 66.66% |
| 2006-12-31 | 4.98 | 60.13% |
| 2005-12-31 | 3.11 | 0.9% |
| 2004-12-31 | 3.08 | |
| 2003-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.25 | 2.16% | 🇺🇸 USA |
 Novartis NVS | 5.00 | -2.72% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.76 | -65.79% | 🇺🇸 USA |
 Eli Lilly LLY | 66.1 | 1,187.73% | 🇺🇸 USA |
 Merck MRK | 8.63 | 68.10% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 5.35 | 4.24% | 🇺🇸 USA |
 MannKind Corp MNKD | -4.82 | -193.81% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -0.8575 | -116.70% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 3.21 | -37.42% | 🇺🇸 USA |